Through TIMER, our study showed that TP53 status significantly affected the level of CD8+ T cell infiltration in 5 out of 30 cancer types, including HNSC, kidney chromophobe (KICH), LUAD, STAD, and UCEC (Figure 2; Supplementary Figures S1-S3). This evidence concerns the gene TP53 and cancer.